Mandate

Vinge has advised Byggfakta in connection with its listing on Nasdaq Stockholm

The first day of trading on Nasdaq Stockholm large cap was 15 October 2021. The offer price was SEK 75 per share, equivalent to a market value for the Byggfakta Group of approximately SEK 16.4 billion. The offer covers 64,483,197 shares together with an oversubscription option to a total value of approximately SEK 5.5 billion.

Byggfakta Group, with its registered office in Ljusdal, Sweden, and dating back to 1936, is a leading digital platform which offers solutions which match actors in the building industry’s value chain, maximizes sales and improves efficiency for its customers.

Vinge’s team primarily consisted of Anders Strid, Rikard Lindahl, Edin Agic, Lina André, Linus Adolfsson, David Bokliden, Adrian Filipovic and Jacob Benzow (Capital Markets and Public M&A), Magnus Pauli (M&A), Albert Wållgren, Linn Adelwald, Ludvig Wettergren (Banking and Finance), Maria Schultzberg, Victor Ericsson and Emelie Svanberg (Tax), Anna-Maria Lagerqvist Gahm, Anna Högsten and Stina Karinsdotter (IP/IT), Rebecka Hansson (Employment) and Viktoria Owetz Leyva and Nathalie Hughes (VDR).

Related

Vinge advised Precise Biometrics

Vinge has advised Precise Biometrics AB in connection with the merger with Fingerprint Cards.
March 27, 2026

Vinge has advised Xspray Pharma in connection with its rights issue

Vinge has advised Xspray Pharma AB (publ) in connection with a rights issue of approximately SEK 83 million before transaction costs, with an over-allotment issue of approximately SEK 30 million.
March 26, 2026

Vinge advises Diamyd Medical in connection with directed issuances of shares and warrants of up to SEK 1,166 million

Vinge advises Diamyd Medical Aktiebolag (“Diamyd Medical”), listed on Nasdaq First North Growth Market, in connection with directed issuances of shares and warrants whereby Diamyd Medical receives gross proceeds of approximately SEK 1,166 million, if all warrants are exercised.
March 25, 2026